NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NASDAQ · Medical Distribution · USD

Cellyan Biotechnology Co., Ltd (HKPD) Stock Analysis

Cellyan Biotechnology Co., Ltd (HKPD) is a Medical Distribution stock listed on NASDAQ and quoted in US Dollar.

HKPD

$0.13

−$0.01 (−8.57%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare HKPD with… →

HKPD Key Statistics

As of Sep 4, 2026
Trading
Open
$0.14
Previous Close
$0.14
Day's Range
0.12–0.14
52-Week Range
0.12–1.82
Volume
2.31M
Valuation
Market Cap
$6.19M
P/E Ratio
unprofitable
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
0.46
EPS (ttm)Profit attributable to each share over the last twelve months.
−0.06
Financials (FY)
Revenue (FY)
$20.31M+21.72%
Net Income (FY)
−$27.06K−102.03%
Profit marginThe share of revenue left as profit after all costs and taxes.
−8.46%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
41.35M
1-Year Return
−87.69%
Dividend and dates
Avg Volume
2.65M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

HKPD Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−84.47%
2025−70.78%

As of September 4, 2026.

HKPD Revenue and Earnings by Fiscal Year

FY ends March
Fiscal yearRevenueNet incomeNet margin
2024$20.31M−$27.06K−0.1%
2023$16.69M$1.33M8.0%
2022$12.56M$998.20K7.9%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2024$20.31M$2.42M$200.77K−$27.06K−0.1%
2023$16.69M$3.56M$1.67M$1.33M8.0%
2022$12.56M$2.74M$1.08M$998.20K7.9%

Annual figures as reported, in the company's reporting currency. As of March 31, 2025.

HKPD Valuation vs Medical Distribution Median

Median of 13 stocks
MetricHKPDMedical Distribution medianvs median
P/S ratio0.460.3628% above
Profit margin−8.46%−4.03%4.4 pts below

Medians across 13 Medical Distribution stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Analysis

Data-derived

Company Overview

Cellyan Biotechnology Co., Ltd (HKPD) carries a market capitalisation of $6.19M. It is classified in the Medical Distribution industry, within the Healthcare sector. The company reports 11 employees.

The 52-week range on file runs from $0.12 to $1.82. The most recent close on file for HKPD is $0.13, dated September 4, 2026. That is −$0.01 (−8.57%) against the previous close. The latest close sits 3.48% above that 52-week low.

Financial Health

In fiscal 2024, Cellyan Biotechnology Co., Ltd reported revenue of $20.31M. Against the prior fiscal year total of $16.69M, that is a change of +21.72%. The same year closed with a net loss of $27.06K. Profit margin runs at −8.46%. That is 4.4 percentage points below the Medical Distribution median of −4.03%. Earnings per share on a trailing basis come to −0.06.

Across the 3 fiscal years on file, revenue moves from $12.56M in 2022 to $20.31M in 2024. Of those 3 years, 2 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published. Measured against sales, the shares trade at 0.46 times revenue. On price-to-sales that is 27.53% above the Medical Distribution median of 0.36. The medians here are taken across 13 Medical Distribution companies that report the metric.

The trailing one-year price return is −87.69%. The stored price history starts on January 15, 2025, and the total return since then is −95.46%. Daily returns over the trailing 1 year annualize to a volatility of 118.93%.

Growth & Income

No dividend is on file for HKPD.

The record holds one complete calendar year, 2025, which returned −70.78%. So far in 2026 the price is −84.47%.

Peer Comparison

Cellyan Biotechnology Co., Ltd (HKPD) operates in the Medical Distribution industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Cellyan Biotechnology Co., Ltd HKPD $6.19M —
McKesson Corporation MCK $105.86B 24.7
Cencora, Inc. COR $63.15B 25.1
Cardinal Health, Inc. CAH $57.49B 34.4

The Medical Distribution industry average P/E ratio is 25.8x. Cellyan Biotechnology Co., Ltd has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Distribution Stocks

MCK

McKesson Corporation

$105.86B

 COR

Cencora, Inc.

$63.15B

 CAH

Cardinal Health, Inc.

$57.49B

 HSIC

Henry Schein, Inc.

$10.01B

 AHG

Akso Health Group

$726.49M

 FOCL

EDAP TMS S.A.

$190.70M
View all Medical Distribution stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About Cellyan Biotechnology Co., Ltd

Cellyan Biotechnology Co., Ltd, an investment holding company, engages in the over-the counter (OTC) pharmaceutical business in Hong Kong and Mainland China. The company provides OTC pharmaceutical cross-border procurement and distribution and e-commerce supply chain services. It also offers customs clearance, drugs enlisting, warehouse, and other logistics services. In addition, it provides value-added services such as labeling, extended storage, product inspection, batch processing, and logistics support, as well as sales of health supplements and non-pharmaceutical products. The company serves e-commerce platform logistics partners, merchants, and Chinese e-commerce platforms as well as pharmaceutical distributors. The company was formerly known as Hong Kong Pharma Digital Technology Holdings Limited and changed its name to Cellyan Biotechnology Co., Ltd in December 2025. Cellyan Biotechnology Co., Ltd was incorporated in 2023 and is based in Yau Tong, Hong Kong.

Visit website →